Defective expression of MHC class I antigens is frequent in B‐cell lymphomas of high‐grade malignancy

International Journal of Cancer

Volumn 40, Issue 1, 1987, Pages 32-39

  Moller P ^a   Herrmann, B ^a   Moldenhauer, G ^b   Momburg, F ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; B CELL LYMPHOMA; CYTOLOGY; DIAGNOSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHATIC SYSTEM; LYMPHOBLASTOMA; PRIORITY JOURNAL; PROGNOSIS;

ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; BETA 2-MICROGLOBULIN; HISTOCOMPATIBILITY ANTIGENS; HISTOCYTOCHEMISTRY; HLA ANTIGENS; HUMAN; LYMPHOMA; SUPPORT, NON-U.S. GOV'T;

EID: 0023222449     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910400107     Document Type: Article

References (62)

1. Phenotypic characterization of “non‐T, non‐B” acute lymphoblastic leukemia by a new panel (bL) of monoclonal antibodies
2. 2‐Microglobulin
3. Reactivity of human lymphoid and lymphoblastoid cells with peanut agglutinin: detection of a blood cell subset which lacks detectable membrane HLA
4. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens‐New tools for genetic analysis
5. Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T‐Cell immunity
6. Location of T cell and major histocompatibility complex antigens in the human thynius
7. Clinical and prognostic relevance of the Kiel classification of non‐Hodgkin lymphomas. Results of a prospective multicenter study by the Kiel Lymphoma Study Group
8. 2‐Microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens
9. The distribution of HLA on human lymphoid, bone marrow and peripheral blood cells
10. 2‐Microglobulin, a tumour marker of lymphoproliferative disorders
11. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA‐A, B antigens in vascular endothelial cells and dermal fibroblasts in vitro
12. Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms
13. The detailed distribution of HLA‐A,B,C antigens in normal human organs
14. The tissue distribution and cellular location of transplantation antigens
15. MHC antigens and non‐Immune functions
16. Deficient expression of class‐I HLA in some cases of acute leukemia
17. Distribution of HLA class I antigens in normal human tissue and in mammary cancer
18. K
19. Immunoglobulin negative follicle centre cell lymphoma
20. 2 microglobulin and HLA antigens on human lymphoid cells by interferon
21. 2‐MicrogIobulin and histocompatibility antigens on human peripheral blood lymphocytes in vitro
22. 2 microglobulin in eccrine porocarcinoma
23. Clinical relevance of immunologic phenotype in diffuse large cell lymphoma
24. Rejection of transplantable AKS leukaemia cells following MHC DMA‐Mediated cell transformation
25. Serological identification of HLA‐A‐Iinked human “la‐Type” antigens
26. Surface immunoglobulin pattern of the leukaemic cell population in chronic lymphocytic leukaemia (cLL) in relation to disease activity
27. − (“null‐Cell”) non‐Hodgkin's lymphomas: multiparametric determination of their B‐ or T‐Lineage
28. 2‐Microglobulin on human neuroblastoma cells lines
29. Malignant lymphomas other than Hodgkin's disease
30. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis of the clonal level of the cytolysis‐Inhibiting effect of 7 monoclonal antibodies
31. A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody
32. Primary mediastinal clear cell lymphoma of B‐Cell type
33. The primary mediastinal clear cell lymphoma of B‐Cell type has variable defects in MHC antigen expression
34. The mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation
35. Loss of HLA‐A,B,C and de novo expression of HLA‐D in colorectal cancer
36. B cell/Leukemia panel workshop: summary and comments
37. Distribution of human class I (hLA‐A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin
38. 2‐Microglobulin in normal and malignant human cell lines and peripheral lymphocytes
39. 2‐Microglobulin on human lymphoid cells induced by human interferon‐α in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment
40. Use of a monoclonal antibody (w6/32) in structural studies of HLA‐A,B,C antigens
41. HD37 monoclonal antibody: a useful reagent for further characterization of “non‐T, non‐B” lymphoid malignancies
42. Cell‐Free translation of the mRNAs for the heavy and light chains of HLA‐A and HLA‐B antigens
43. Major histocompatibility antigens: the human (hLA‐A,‐B,‐C) and murine (h‐2K, H‐2D) class I molecules
44. A study of malignant tumours in Nigeria by short‐Term culture
45. Tumors of the hematopoietic system
46. 2‐Microglobulin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon
47. Cross‐Linking of insulin receptors to MHC antigens in human B lymphocytes: evidence for selective molecular interactions
48. 2‐Microglobulin and immunoselection in the pathway to malignancy
49. Resistance to cell‐Mediated cytotoxicity is correlated with reduction of H‐2K gene products in AKR leukemia
50. Failure of lymphocyte‐Membrane HLA‐A and ‐B expression in two siblings with combined immunodeficiency
51. HL‐A antigenic loss in malignant transformation
52. Characterization of a human B lymphocyte‐Specific antigen
53. Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene
54. Phorbol ester‐Induced production of beta‐2‐Microglobulin in B‐C11 cells: relation to IgM secretory response and disease activity
55. Combined immunodeficiency disease associated with the absence of cell‐Surface HLA‐A and ‐B antigens
56. Expression of HLA‐A, ‐B, and ‐C, and ft‐Microglobulin antigens in human choriocarcinoma cell lines
57. 2‐Microglobulin from the cell surface of cutaneous malignant and premalignant lesions
58. Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells
59. De novo expression of H‐2K antigens on tnetastatic tumor cells following H‐2 gene transfection results in abrogation of their metastatic properties
60. Distribution and quantitation of HLA‐A,B,C and DR (la) antigens on human kidney and other tissues
61. Altered expression of histocompatibility antigens on “b” large cell lymphomas
62. MHC cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T‐Cell restriction‐Specificity, function and responsiveness